Novo Nordisk Obesity Pill Spurs Rebound From Stock’s Worst Year
Novo Nordisk A/S shares are bouncing back from their worst ever year, with bulls hoping that a pill version of its blockbuster obesity shot will help finally turn things around...
By Lisa Pham · Bloomberg Markets
Novo Nordisk A/S shares are bouncing back from their worst ever year, with bulls hoping that a pill version of its blockbuster obesity shot will help finally turn things around for the Danish drugmaker.